相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.2K

2025年个体辐射敏感性测试:个性化放射治疗的当前进展和未来方向

Kamel Debbi1, Nhu Hanh To1, Allan Thiolat2

  • 1Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, APHP, UPEC, Créteil, France; Institut Mondor de Recherche Biomédicale (IMRB), INSERM U955, i-Biot, UPEC, Créteil, France.

Critical reviews in oncology/hematology
|September 15, 2025
PubMed
概括

预测个人辐射敏感性 (RS) 是个性化放射治疗的关键. 最近的进展显示出有前途,辐射诱导淋巴细胞亡 (RILA) 试验是预测治疗毒性的最有临床验证的方法.

关键词:
生物标志物 生物标志物里拉拉里拉里拉里拉里拉里拉里拉放射治疗疗法 放射治疗疗法辐射敏感性 辐射敏感性衰老是一种衰老.毒性预测 毒性预测

更多相关视频

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.1K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.7K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K